Sarah Whelan, PhD
Science Writer
at Technology Networks
Sarah joined Technology Networks in 2022 after completing a PhD in cancer biology, where her research focused on the development of colon cancers. In her role as science writer and editor, Sarah covers scientific news and a range of other content types, leading the site's coverage of drug discovery, biopharma and cancer research content.
Education
Areas of Expertise
Got a Question for Sarah Whelan, PhD?
Get in touch using the contact form linked here and we’ll get back to you shortly
Published Content
Total: 291
News
Could Genetics Influence Cancer Risk From Red and Processed Meats?
Researchers have explored whether genetics can influence the risk of colorectal cancer from the consumption of red and processed meat, identifying two genetic markers that may put some people at increased risk.
News
Alzheimer’s Drug Production a Step Closer With the Help of Bacteria and AI
Researchers have developed a microbial fermentation method to produce galantamine with the help of artificial intelligence (AI) and biosensors.
News
Genetic “Dark Matter” Could Help Monitor Cancer
Researchers from the Johns Hopkins Kimmel Cancer Center have developed a machine-learning approach that identifies these sequences in both tumor DNA and cell-free DNA (cfDNA) that are shed into the blood.
News
FDA To Delay Decision on New Alzheimer’s Drug Candidate
A candidate drug for Alzheimer’s disease, donanemab, will be further scrutinized by a US Food and Drug Administration (FDA) expert panel, drugmaker announces.
News
Vitamin A’s Role in Skin Influences Wound Repair and Hair Growth
Retinoic acid, a form of vitamin A, can regulate lineage plasticity in skin stem cells, suggests a new study that could have clinical implications for regenerative medicine, wound healing and even cancer.
News
Experimental Drug Shows Early Promise for Rare, Incurable Brain Tumors
A study of five early-stage clinical trials has found that an experimental drug may have favorable results for a rare and incurable type of brain tumor, for which there are very few treatment options.
News
Stimulating Brain Waves May Protect Against “Chemobrain”
A method to stimulate gamma brain waves could pave the way for a non-invasive treatment for so-called “chemobrain”, according to a new study from MIT researchers.
Industry Insight
Using Predictive Tools To Bring Drugs to Market Faster
We spoke to Olivier Barberan, director of Translational Medicine Solutions at Elsevier, to find out more about how predictive tools can inform pharma companies and help pave the way for drugs to get to market.
News
Gut Microbiome May Identify Cancer Patients Who Will Respond to Immunotherapy
A signature of bacterial strains in the gut microbiome may be able to identify cancer patients that will respond well to certain immunotherapy drug combinations, according to a new study from Wellcome Sanger Institute and Olivia Newton-John Cancer Research Institute researchers.
News
The Gut–Brain Axis May Not Operate as Previously Thought
New information on how the gut and brain communicate has been uncovered by Flinders University researchers in a development that could influence how we make and use certain drugs, such as antidepressants.
Advertisement
